Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative ...
Singapore has a similarly ambitious target to reach net zero by 2050 – with the crucial difference that the industries most ...
NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
ServiceNow's acquisition of Logik.ai represents the company's continued strategic expansion into the CRM space, while ...